Procter & Gamble’s fiscal first-quarter organic sales growth faces balanced uncertainty driven by persistent input-cost pressures and a modest volume recovery. The company’s FY2027 guidance embeds 1–3% organic growth after a 30–50 basis-point headwind from portfolio rationalization, alongside roughly $1 billion in after-tax commodity, energy, and logistics costs that are expected to weigh most heavily in the first half. Recent U.S. category volumes have stabilized with a 40-basis-point sequential improvement, while e-commerce share losses have halted and higher-margin brands such as Olay, Pantene, and Dawn are outpacing core categories. Analyst estimates for the quarter cluster around 2%, with some upward revisions to 3% reflecting better mix and pricing power, yet the low end of guidance remains vulnerable if consumer spending softens further or competitive promotions intensify. Earnings results, due later this month, will provide the key catalyst to clarify whether the 1–3% annual range holds in the near term.